3,042 reports of this reaction
1.8% of all MEPOLIZUMAB reports
#10 most reported adverse reaction
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION is the #10 most commonly reported adverse reaction for MEPOLIZUMAB, manufactured by GlaxoSmithKline LLC. There are 3,042 FDA adverse event reports linking MEPOLIZUMAB to SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION. This represents approximately 1.8% of all 173,706 adverse event reports for this drug.
Patients taking MEPOLIZUMAB who experience sleep disorder due to a general medical condition should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION is a less commonly reported adverse event for MEPOLIZUMAB, but still significant enough to appear in the safety profile.
In addition to sleep disorder due to a general medical condition, the following adverse reactions have been reported for MEPOLIZUMAB:
The following drugs have also been linked to sleep disorder due to a general medical condition in FDA adverse event reports:
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION has been reported as an adverse event in 3,042 FDA reports for MEPOLIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION accounts for approximately 1.8% of all adverse event reports for MEPOLIZUMAB, making it a notable side effect.
If you experience sleep disorder due to a general medical condition while taking MEPOLIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.